The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry

  • S Friedrich, U Zeymer, R Dechend, I Hagedorn, T Riemer, C Zemmrich, P Bramlage, D Pittrow, J Senges, R E Schmieder
  • Journal of Human Hypertension, October 2014, Springer Science + Business Media
  • DOI: 10.1038/jhh.2014.86

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Peter Bramlage